由来生物
mouse
抗体製品の状態
purified immunoglobulin
抗体製品タイプ
primary antibodies
クローン
PI-11, monoclonal
化学種の反応性
human
化学種の反応性(ホモロジーによる予測)
rat (based on 100% sequence homology)
テクニック
immunocytochemistry: suitable
immunofluorescence: suitable
immunohistochemistry: suitable (paraffin)
western blot: suitable
アイソタイプ
IgG1κ
NCBIアクセッション番号
UniProtアクセッション番号
輸送温度
dry ice
ターゲットの翻訳後修飾
unmodified
遺伝子情報
human ... CAST(831)
詳細
Calpastatin (UniProt P20810; also known as Calpain inhibitor, Sperm BS-17 component) is encoded by the CAST gene (Gene ID 831) in human. Calpastatin is a ubiquitously expressed protein that functions as the endogenous inhibitor of both calpain 1 and 2 (micro-calpain and m-calpain, respectively). Calpastatin contains four inhibitory repeats, each of which neutralizes an activated calpain with exquisite specificity and potency. Fully activated calpain binds ten Ca(2+) ions, resulting in several conformational changes allowing recognition by calpastatin. Calpain inhibition is mediated by the intimate contact with three critical regions of calpastatin. Two regions target the penta-EF-hand domains of calpain and the third occupies the substrate-binding cleft, projecting a loop around the active site thiol to evade proteolysis. The inhibitory domain of calpastatin recognizes multiple lower affinity sites present only in the calcium-bound form of the enzyme, resulting in an interaction that is tight, specific and calcium dependent.
特異性
Reacts with human calpastatin.
免疫原
Human erythrocyte calpastatin.
アプリケーション
Research Category
ニューロサイエンス
ニューロサイエンス
Research Sub Category
ニューロン発生
ニューロン発生
Immunohistochemistry Analysis: A 1:250 dilution from a representative lot detected Calpastatin in human prostate cancer tissue, as well as normal testis and kidney tissues.
Immunohistochemistry Analysis: A representative lot detected both cytoplasmic and nuclear calpastatin immunoreactivity in cancer cells using paraffin-embedded pancreatic adenocarcinoma, as well as bile duct and ampullary tumour tissue sections (Storr, S.J., et al. (2012). BMC Cancer. 12:511).
Immunohistochemistry Analysis: A representative lot detected the exogenously expressed human calpastatin, but not the endogenous rat calpastatin, in frozen rat heart tissue sections (Maekawa, A., et al. (2003). J. Mol. Cell. Cardiol. 35(10):1277-1284).
Immunocytochemistry Analysis: A representative lot detected exogenously expressed human calpastatin, but not the endogenous rat calpastatin, in primary rat cortical neurons by fluorescent immunocytochemistry (Ma, M., et al. (2012). J. Neurotrauma. 29(16): 2555–2563).
Immunocytochemistry Analysis: A representative lot detected calpastatin intracellular localization in proliferating A431 cells (Lane, R.D., et al. (1992), Exp. Cell. Res. 203(1):5-16).
Immunofluorescence Analysis: A representative lot detected the exogenously expressed human calpastatin, but not the endogenous rat calpastatin, in retinal ganglion cells (RGCs) by fluorescent immunohistochemical staining of retinal flat mounts (Ma, M., et al. (2012). J. Neurotrauma. 29(16): 2555–2563).
Western Blotting Analysis: Representative lots detected exogenously expressed human calpastatin, but not the endogenous rat calpastatin, in rat optical nerve and heart tissue homogenates (Ma, M., et al. (2012). J. Neurotrauma. 29(16): 2555–2563; Maekawa, A., et al. (2003). J. Mol. Cell. Cardiol. 35(10):1277-1284).
Western Blotting Analysis: A representative lot detected a 75% increase of rat brain calpastatin level during development from E18 to P90 (Li. Y., et al. (2009). Exp. Neurol. 220(2):316-319).
Western Blotting Analysis: Representative lots detected endogenous calpastatin in rat heart tissue homogenates (Takahashi, M., et al. (2006). J. Cardiovasc. Pharmacol. 47(3):413-421; Takahashi, M., et al. (2005). Cardiovasc. Res. 65(2):356-365; Yoshida, H., et al. (2003). Cardiovasc. Res. 59(2):419-427).
Western Blotting Analysis: A representative lot detected calpastatin in lysates from untransfected SH-SY5Y cells as well as transfected SH-SY5Y cells overexpressing human calpastatin (Neumar, R.W., et al. (2003). J. Biol. Chem. 278(16):14162-14167).
Immunohistochemistry Analysis: A representative lot detected both cytoplasmic and nuclear calpastatin immunoreactivity in cancer cells using paraffin-embedded pancreatic adenocarcinoma, as well as bile duct and ampullary tumour tissue sections (Storr, S.J., et al. (2012). BMC Cancer. 12:511).
Immunohistochemistry Analysis: A representative lot detected the exogenously expressed human calpastatin, but not the endogenous rat calpastatin, in frozen rat heart tissue sections (Maekawa, A., et al. (2003). J. Mol. Cell. Cardiol. 35(10):1277-1284).
Immunocytochemistry Analysis: A representative lot detected exogenously expressed human calpastatin, but not the endogenous rat calpastatin, in primary rat cortical neurons by fluorescent immunocytochemistry (Ma, M., et al. (2012). J. Neurotrauma. 29(16): 2555–2563).
Immunocytochemistry Analysis: A representative lot detected calpastatin intracellular localization in proliferating A431 cells (Lane, R.D., et al. (1992), Exp. Cell. Res. 203(1):5-16).
Immunofluorescence Analysis: A representative lot detected the exogenously expressed human calpastatin, but not the endogenous rat calpastatin, in retinal ganglion cells (RGCs) by fluorescent immunohistochemical staining of retinal flat mounts (Ma, M., et al. (2012). J. Neurotrauma. 29(16): 2555–2563).
Western Blotting Analysis: Representative lots detected exogenously expressed human calpastatin, but not the endogenous rat calpastatin, in rat optical nerve and heart tissue homogenates (Ma, M., et al. (2012). J. Neurotrauma. 29(16): 2555–2563; Maekawa, A., et al. (2003). J. Mol. Cell. Cardiol. 35(10):1277-1284).
Western Blotting Analysis: A representative lot detected a 75% increase of rat brain calpastatin level during development from E18 to P90 (Li. Y., et al. (2009). Exp. Neurol. 220(2):316-319).
Western Blotting Analysis: Representative lots detected endogenous calpastatin in rat heart tissue homogenates (Takahashi, M., et al. (2006). J. Cardiovasc. Pharmacol. 47(3):413-421; Takahashi, M., et al. (2005). Cardiovasc. Res. 65(2):356-365; Yoshida, H., et al. (2003). Cardiovasc. Res. 59(2):419-427).
Western Blotting Analysis: A representative lot detected calpastatin in lysates from untransfected SH-SY5Y cells as well as transfected SH-SY5Y cells overexpressing human calpastatin (Neumar, R.W., et al. (2003). J. Biol. Chem. 278(16):14162-14167).
This Anti-Calpastatin Antibody, clone PI-11 (Ascites Free) is validated for use in Western Blotting, Immunohistochemistry (Paraffin), Immunocytochemistry and Immunofluorescence for the detection of Calpastatin.
品質
Evaluated by Western Blotting in MDA-MB-231 cell lysate.
Western Blotting Analysis: 0.5 µg/mL of this antibody detected Calpastatin in 10 µg of MDA-MB-231 cell lysate.
Western Blotting Analysis: 0.5 µg/mL of this antibody detected Calpastatin in 10 µg of MDA-MB-231 cell lysate.
ターゲットの説明
~110/120 kDa observed. Target band(s) appear larger than the calculated molecular weights due to posttranslational modifications.
関連事項
Replaces: MAB3084
物理的形状
Protein G Purified
Format: Purified
Purified mouse monoclonal IgG1κ antibody in buffer containing 0.1 M Tris-Glycine (pH 7.4), 150 mM NaCl without preservatives.
保管および安定性
Stable for 1 year at -20°C from date of receipt.
Handling Recommendations: Upon receipt and prior to removing the cap, centrifuge the vial and gently mix the solution. Aliquot into microcentrifuge tubes and store at -20°C. Avoid repeated freeze/thaw cycles, which may damage IgG and affect product performance.
Handling Recommendations: Upon receipt and prior to removing the cap, centrifuge the vial and gently mix the solution. Aliquot into microcentrifuge tubes and store at -20°C. Avoid repeated freeze/thaw cycles, which may damage IgG and affect product performance.
その他情報
Concentration: Please refer to lot specific datasheet.
免責事項
Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
適切な製品が見つかりませんか。
製品選択ツール.をお試しください
保管分類コード
12 - Non Combustible Liquids
WGK
WGK 1
引火点(°F)
Not applicable
引火点(℃)
Not applicable
適用法令
試験研究用途を考慮した関連法令を主に挙げております。化学物質以外については、一部の情報のみ提供しています。 製品を安全かつ合法的に使用することは、使用者の義務です。最新情報により修正される場合があります。WEBの反映には時間を要することがあるため、適宜SDSをご参照ください。
Jan Code
MAB3084-C:
試験成績書(COA)
製品のロット番号・バッチ番号を入力して、試験成績書(COA) を検索できます。ロット番号・バッチ番号は、製品ラベルに「Lot」または「Batch」に続いて記載されています。
Journal of cardiovascular pharmacology, 47(3), 413-421 (2006-04-25)
Changes in proteolytic activity of the myocardium during the development of heart failure after left coronary artery ligation (CAL) of rats were examined. Hemodynamics of the rats at the eighth week (8w-CAL rat), but not at the second week (2w-CAL
The Journal of biological chemistry, 278(16), 14162-14167 (2003-02-11)
Cross-talk between calpain and caspase proteolytic systems has complicated efforts to determine their distinct roles in apoptotic cell death. This study examined the effect of overexpressing calpastatin, the specific endogenous calpain inhibitor, on the activity of the two proteolytic systems
Cardiovascular research, 59(2), 419-427 (2003-08-12)
Genetic defects in several sarcoglycans (SGs) and dystrophin (Dys) play a critical role in cardiomyopathy. The present study was designed to determine whether changes in SGs and Dys might occur in animals with chronic heart failure (CHF) induced by acute
Cardiovascular research, 65(2), 356-365 (2005-01-11)
Genetic depletion of dystrophin-related protein (DRP) complex causes cardiomyopathy in animals and humans. We found in a previous study that some types of DRP were degraded and that calpain content was increased in rats with non-genetically induced heart failure. The
Journal of molecular and cellular cardiology, 35(10), 1277-1284 (2003-10-02)
Calpain is a Ca(2+)-activated neutral protease that supposedly plays a key role in myocardial dysfunction following ischemia/reperfusion, by degrading certain proteins involved in the contraction mechanism. It is possible that overexpression of calpastatin, an endogenous calpain inhibitor, lessens contractile dysfunction
ライフサイエンス、有機合成、材料科学、クロマトグラフィー、分析など、あらゆる分野の研究に経験のあるメンバーがおります。.
製品に関するお問い合わせはこちら(テクニカルサービス)